Progenics Pharmaceuticals Inc (PGNX)

Trade PGNX now with

RTTNews Articles

Date	Headline
5/10/2013 8:55:27 AM	Pre-market Movers For May 10 (DELL, PGNX, CRIS, UBNT, PTIE)
5/10/2013 7:30:53 AM	Progenics Pharmaceuticals Q1 Net Loss $11.3 Mln Or $0.22 Per Share
3/15/2013 7:56:19 AM	Progenics Pharmaceuticals Q4 Loss Narrows - Quick Facts
3/15/2013 7:44:02 AM	Progenics Pharma Q4 Loss/Shr $0.01 Vs. Loss $0.32 Last Year
3/15/2013 7:31:11 AM	Progenics Pharmaceuticals Q4 12 Earnings Conference Call At 8:30 AM ET
3/5/2013 9:38:45 AM	Progenics Reports Positive Data From Novel Small Molecules Study Targeting PSMA
3/5/2013 9:08:34 AM	Progenics Pharma Reports Positive Data From Novel Small Molecule Drugs Targeting Prostate-specific Membrane Antigen
1/23/2013 4:10:31 AM	MAPP Bought Out, TELK Rises, TSOI, AMPE Begin Anew, EDAP On High, CLSN Heats Up
12/17/2012 9:20:00 AM	MedImmune Signs Agreement With Progenics For Clostridium Difficile Program
12/17/2012 9:06:48 AM	MedImmune Signs In-licensing Agreement With Progenics For Clostridium Difficile Late-stage Preclinical Program
11/29/2012 11:05:21 AM	Progenics Pharma Prices $22 Mln Stock Offering
11/29/2012 9:02:08 AM	Progenics Pharma Prices Public Offering Of Common Stock
11/28/2012 4:18:23 PM	Progenics Pharma Announces Proposed Stock Offering
11/28/2012 4:11:31 PM	Progenics Pharma Announces Proposed Public Offering Of Common Stock
11/8/2012 7:38:34 AM	Progenics Pharma Q3 Loss/Shr $0.33 Vs. Loss $0.34 Last Year
11/8/2012 7:30:39 AM	Progenics Pharmaceuticals Q3 12 Earnings Conference Call At 8:30 AM ET
9/28/2012 8:13:56 AM	Progenics Commences Phase 2 Trial Of PSMA ADC In Prostate Cancer Patients
9/28/2012 8:07:21 AM	Progenics Pharma Begins Phase 2 Clinical Trial Of PSMA ADC In Prostate Cancer Patients
9/20/2012 5:35:21 PM	Progenics Pharma Reduces 26% Of Workforce - Quick Facts
9/20/2012 4:20:33 PM	Progenics Pharma Announces Companywide Restructuring, Including Reduction Of Workforce

Previous 20 Headlines